Abiomed restates three years' financial results
This article was originally published in Clinica
Executive Summary
Implantable replacement heart manufacturer Abiomed is restating its financial results for the past three years in order to reflect modifications to its accounting methods. The Danvers, Massachusetts-based company says that its overall capital resources are not affected by the changes, which relate to the timing of how it recorded some revenues.